Patent · US Active

Macrocyclic indole derivatives useful as hepatitis C virus inhibitors

US8921355B2 · kind B2 · utility

3Cited by

4References

18Claims

0Family size

Assignee

Janssen R & D Ireland · IE

Inventors

Sandrine Marie Helene Vendeville · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Tse-I Lin · Mechelen, BE
Abdellah Tahri · Anderlecht, BE
Katie Ingrid Eduard Amssoms · Hove, BE

Key dates

Filing date	Jul 8, 2009
Grant date	Dec 30, 2014
Priority date	—
Expiry date	Jan 2, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D515/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R1, R2, R4, R5, R6 and R7 have the meaning defined in the claims. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.